Mistry Ritesh, Gokhman Izabella, Bastani Roshan, Gould Robert, Jimenez Elvira, Maxwell Annette, McDermott Charles, Rosansky Joel, Van Stone William, Jarvik Lissy
Department of Psychiatry and Biobehavioral Sciences, and Neuropsychiatric Institute and Hospital, University of California, Los Angeles, USA.
J Gerontol A Biol Sci Med Sci. 2004 Oct;59(10):1068-75. doi: 10.1093/gerona/59.10.m1068.
A quantitative measure of medical burden is needed to assess medical comorbidities in psychogeriatric patients. The Cumulative Illness Rating Scale (CIRS) is the most widely used instrument for measuring medical burden in psychogeriatric research. Many clinicians, however, are discouraged by the requirement to project the persistence of acute conditions and therefore do not use the scale. The goal of this pilot study was to determine whether the inclusion of acute medical conditions undermines the usefulness of the CIRS. No such comparison was found in the existing literature.
Included in this study were 95 patients previously enrolled in the Unified Psychogeriatric Biopsychosocial Evaluation and Treatment (UPBEAT) demonstration program. All were male veterans of the U.S. armed forces who were admitted to acute medical or surgical inpatient units and who had positive screening results for anxiety, depression, or alcohol abuse. Two types of retrospective CIRS ratings were made for each patient: one included (CIRS-IP) and the other excluded (CIRS-PH) acute conditions. For each type of rating (CIRS-IP and CIRS-PH), 7 CIRS scores were computed according to methods reported in the literature. Survival time during 24 months of follow-up was used as a measure of health outcome indicating medical burden.
With 1 exception, CIRS-IP and corresponding CIRS-PH scores were highly correlated (.70 < r <.99; p <.001). And, for 5 of 7 scores, both CIRS-IP and CIRS-PH were significantly associated with survival time (p <.05).
Results suggest that the CIRS can be used as an indicator of medical burden even with the inclusion of acute conditions. If replicated, these findings may increase CIRS use and thus aid the effort to encourage clinicians working with psychogeriatric patients to use standardized instruments to document medical burden.
需要一种医学负担的定量测量方法来评估老年精神病患者的合并症。累积疾病评定量表(CIRS)是老年精神病学研究中测量医学负担最广泛使用的工具。然而,许多临床医生因需要预测急性病症的持续时间而感到气馁,因此不使用该量表。这项初步研究的目的是确定纳入急性病症是否会削弱CIRS的有用性。现有文献中未发现此类比较。
本研究纳入了95名先前参加统一老年精神病生物心理社会评估与治疗(UPBEAT)示范项目的患者。所有患者均为美国武装部队的男性退伍军人,他们被收治到急性内科或外科住院病房,并且焦虑、抑郁或酒精滥用筛查结果呈阳性。对每位患者进行了两种类型的回顾性CIRS评分:一种包括急性病症(CIRS-IP),另一种排除急性病症(CIRS-PH)。对于每种评分类型(CIRS-IP和CIRS-PH),根据文献报道的方法计算了7个CIRS分数。将24个月随访期间的生存时间用作衡量健康结局的指标,以表明医学负担。
除1例例外,CIRS-IP和相应的CIRS-PH分数高度相关(0.70 < r < 0.99;p < 0.001)。并且,对于7个分数中的5个,CIRS-IP和CIRS-PH均与生存时间显著相关(p < 0.05)。
结果表明,即使纳入急性病症,CIRS仍可作为医学负担的指标。如果得到重复验证,这些发现可能会增加CIRS的使用,从而有助于鼓励治疗老年精神病患者的临床医生使用标准化工具记录医学负担。